Schaper Benz & Wise Investment Counsel Inc. WI Grows Stock Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

Schaper Benz & Wise Investment Counsel Inc. WI lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 9.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,971 shares of the biotechnology company's stock after purchasing an additional 1,669 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI's holdings in Axon Enterprise were worth $9,978,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Fourth Dimension Wealth LLC acquired a new stake in Axon Enterprise during the 4th quarter worth approximately $30,000. Elequin Capital LP acquired a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $46,000. CoreFirst Bank & Trust bought a new stake in shares of Axon Enterprise during the fourth quarter worth $59,000. Global Financial Private Client LLC raised its holdings in shares of Axon Enterprise by 11,100.0% during the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock worth $59,000 after acquiring an additional 111 shares during the period. Finally, Prestige Wealth Management Group LLC raised its holdings in shares of Axon Enterprise by 59.8% during the fourth quarter. Prestige Wealth Management Group LLC now owns 131 shares of the biotechnology company's stock worth $78,000 after acquiring an additional 49 shares during the period. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded down $6.75 during trading on Wednesday, hitting $770.79. 482,785 shares of the company were exchanged, compared to its average volume of 506,310. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. Axon Enterprise, Inc has a 52-week low of $279.02 and a 52-week high of $806.64. The company has a market cap of $60.01 billion, a PE ratio of 186.18, a P/E/G ratio of 89.50 and a beta of 1.29. The stock has a 50 day moving average of $683.57 and a 200 day moving average of $624.47.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. Axon Enterprise's revenue was up 31.3% compared to the same quarter last year. During the same period last year, the business earned $1.15 earnings per share. As a group, equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 9,000 shares of the firm's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the transaction, the president now directly owns 308,714 shares of the company's stock, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock valued at $30,500,428 over the last three months. 4.40% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on AXON. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Barclays increased their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group raised their price objective on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Finally, Needham & Company LLC lifted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.